All posts by: Michael Zand

About Michael Zand

FDA clears Turnstone Biologics’ IND for immunotherapy targeting HPV positive solid tumors – News-Medical.net

Continue reading

2018-05-16 NEWS

News-Medical.net

FDA clears Turnstone Biologics’ IND for immunotherapy targeting HPV positive solid tumors
News-Medical.net
Turnstone’s MG1 virus is the first immunotherapy engineered to function as both a selective tumor-destroying oncolytic virus and an immune stimulating T cell vaccine. MG1 directly attacks cancer cells and modifies the microenvironment to make tumor

Continue reading

2018-05-16 NEWS

Medical Xpress

Generating large numbers of universal immune cells could transform cancer immunotherapy
Medical Xpress
A scalable method of generating universal ‘off-the-shelf’ natural killer (NK) cells for cancer immunotherapies has been devised by A*STAR researchers. Their technique could ensure that future NK cell-based cancer treatments can be used for most patients.